ModivCare Q4 2023 Adj EPS $1.29 Beats $1.28 Estimate, Sales $702.83M Beat $696.72M Estimate
Portfolio Pulse from Benzinga Newsdesk
ModivCare (NASDAQ:MODV) reported Q4 2023 adjusted EPS of $1.29, surpassing the $1.28 estimate, with sales of $702.83M exceeding the $696.72M forecast. This represents a 7.48% increase in sales compared to the same period last year.
February 22, 2024 | 9:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ModivCare reported a Q4 2023 adjusted EPS of $1.29, beating estimates, and sales of $702.83M, also above forecasts, marking a 7.48% increase from the previous year.
Beating both EPS and sales estimates typically has a positive impact on investor sentiment and can lead to a short-term increase in stock price. The reported year-over-year sales growth further strengthens the company's financial position and outlook, making it an attractive asset for investors.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100